|
Stephanie Mgebroff MSc
Director GMP Quality Control
Seattle Children''s Therapeutics
Seattle
USA
|
Stephanie Mgebroff is the Director of GMP Quality Control within the Therapeutic Cell Production Core (TCPC) at Seattle Children’s Therapeutics (SCTx). She has over 18 years of cell therapy and protocol development experience with a focus on manufactured cell products in the phase I/II environment. Mgebroff joined Seattle Children’s in 2011 and played a key role in developing the TCPC infrastructure and standard operating procedures, including quality control policy development and implementation. She came to Seattle Children’s with a background in GMP cell manufacturing and process development from her work at the Fred Hutchinson Cancer Research Center's cellular processing facility and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine. Mgebroff holds a BS in Biology from Gonzaga University and a MSc in Biotechnology from Johns Hopkins University.